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Abstract
Background: Red wine contains a naturally rich source of antioxidants, which may protect the
body from oxidative stress, a determinant of age-related disease. The current study set out to
determine the in vivo effects of moderate red wine consumption on antioxidant status and
oxidative stress in the circulation.
Methods: 20 young (18–30 yrs) and 20 older (≥ 50 yrs) volunteers were recruited. Each age group
was randomly divided into treatment subjects who consumed 400 mL/day of red wine for two
weeks, or control subjects who abstained from alcohol for two weeks, after which they crossed
over into the other group. Blood samples were collected before and after red wine consumption
and were used for analysis of whole blood glutathione (GSH), plasma malondialdehyde (MDA) and
serum total antioxidant status.
Results: Results from this study show consumption of red wine induced significant increases in
plasma total antioxidant status (P < 0.03), and significant decreases in plasma MDA (P < 0.001) and
GSH (P < 0.004) in young and old subjects. The results show that the consumption of 400 mL/day
of red wine for two weeks, significantly increases antioxidant status and decreases oxidative stress
in the circulation
Conclusion: It may be implied from this data that red wine provides general oxidative protection
and to lipid systems in circulation via the increase in antioxidant status.
Background
Efforts to define the role of nutrition in health have cap-
tured researcher's interest in antioxidants and their capac-
ity to protect the body from damage induced by oxidative
stress. Extensive research has demonstrated the protective
properties of antioxidants, which scavenge reactive oxy-
gen species (ROS) and their precursors, as well as up-reg-
ulate enzymes involved in the repair of cellular damage
[1]. Red wine contains a rich source of a large number of
antioxidants, namely the phenolic acids and polyphenols,
which provide it with its protective redox potential [2,3].
Epidemiological studies have shown that despite the high
intake of saturated fatty acids within the diets of some
populations, a reduced mortality rate from cardiovascular
disease is attributed to the high consumption of red wine,
independent of its alcohol content, the 'French Paradox'
[4]. Studies also indicate that sub-populations already at a
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may potentially experience a greater beneficial effect from
moderate wine consumption [5]. Moderate consumption
of red wine has also been shown to retard or slow the
plasma clearance of high density lipoproteins (HDL), a
negative risk factor for the development of cardio vascular
disease (CVD). In doing so, a positive correlation between
HDL particles and moderate red wine intake becomes evi-
dent [6]. Furthermore, the incubation of low density lipo-
proteins LDL) in varying concentrations of red and white
wine showed a 50% decline in oxidation at concentra-
tions of 0.04 and 0.7 mg/ethanol/mL respectively, up to a
concentration of 1.0 mg/mL. These results indicate that
red wine inhibits cell mediated LDL oxidation more effi-
ciently then white wine and at much lower concentra-
tions.
To investigate further, the relationship between red wine
consumption and oxidative damage in humans has been
studied by Greenrod and Fenech [7], in a series of in vitro
and ex vivo study designs. They demonstrated a strong (>
70%) reduction in H2O2 induced genetic damage after 1-
hour post consumption of 300 mL of red wine. These
findings are also supported by a similar study by Szeto
and Benzie [8], showing that DNA damage was signifi-
cantly reduced in a H2O2 challenge, with treatment of
caffeic acid, a polyphenol found in red wine.
Oxidative damage to a range of biomolecules is of partic-
ular interest to researchers. The tripeptide glutathione
(GSH) functions as an antioxidant, which scavenges free
radical species in circulation. GSH is oxidized as the
enzyme glutathione peroxidase catalyzes the degradation
of H2O2 [9]. Increasing evidence demonstrates GSH plays
an integral role in the protection against oxidative stress in
the circulation due to its ability to facilitate the recycling
of oxidized α-tocopherol and ascorbic acid, two impor-
tant antioxidants in the circulation and is widely used as a
biomarker of circulating antioxidant levels [10]. Within
plasma fatty acid residues of phospholipids and LDL, are
extremely susceptible to oxidative damage by free radical
intermediates resulting in oxidized fatty acids and peroxi-
dation byproducts, such as conjugated diennes (CD) and
malondialdehyde (MDA) derivatives [11]. MDA appears
to be one of the most toxic and mutagenic aldehydes gen-
erated by lipid peroxidation of polyunsaturated fatty acids
of cell membranes [12]. It is also a popular measurement
used to quantify the effects of radical damage to cellular
lipids [13].
A large body of evidence which indicates that free radical
production can directly or indirectly play a major role in
cellular processes implicated in atherosclerosis and CVD,
[14]. Therefore the aim of this study were firstly to under-
stand how moderate red wine consumption (400 ml/day)
for two weeks effected circulating lipids, antioxidant level
and total antioxidant capacity in the circulation and sec-
ondly assess the differences in bioefficacy of red wine in
young and older populations.
Methods
Recruitment of volunteers
This study protocol was approved by the Human Research
Ethics Committee of Victoria University (HRETH.SET 15/
05). Forty volunteers were selected based upon their
responses to a general health questionnaire and after giv-
ing written informed consent. Those who were taking any
anti-coagulant or anti-inflammatory medications or had a
history of cardiovascular or liver disease were excluded.
Two age groups were selected, these were 20 volunteers
aged between 18–30 years old (young group) and 20 vol-
unteers aged older then 50 years old (older group). Volun-
teers were randomly assigned to begin in the red wine or
control group within their respective age group (Figure 1).
Intervention design
Prior to drinking the red wine or control period volunteers
were asked to abstain from consuming any alcohol,
grapes or grape products for one week. After this one week
lead in subjects had three 10 mL tubes of fasting blood
collected via venipuncture to determine baseline meas-
ures of MDA, GSH, and total antioxidant capacity and
BMI (kg/m2) calculated, after which they began the red
wine or control period. During the red wine period partic-
ipants consumed 400 mL of red wine each day (Cabernet
Outline of studyFigur 1
Outline of study. Volunteers consumed 400 mL/day of red 
wine for two weeks or abstained from consuming alcohol, 
grapes or grape products for two weeks and crossed over 
into the other group after a two week washout.
STUDY POPULATION
n=40 
Young Group 
(18-30yrs) 
n=20
Old Group 
(>50yrs) 
n=20
Control Treatment Control Treatment
2 week washout
3 x 10mL of fasting blood is collected
Week 0
Week 1
Week 3
Week 5
Week 6
Week 8
All participants abstain from consuming alcohol, grapes or grape products
3 x 10mL of fasting blood is collected
Cross over, all participants abstain from consuming alcohol, grapes or grape products 
3 x 10mL of fasting blood is collectedPage 2 of 8
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abstained from other alcohol, grapes or grape products. A
placebo such as alcohol free wine was not used due to dif-
ficulties in matching the flavour and mouth feel of the red
wine used. Instead a crossover design was used whereby
after completing either the red wine or control period vol-
unteers were given a two week washout period before
crossing over into the other group. During the control
period volunteers abstained from consuming any source
of alcohol, grapes or grape products for two weeks. Three
10 mL tubes of fasting blood were again collected after the
treatment or control phase (see Figure 1). Participants
were also encouraged to maintain their usual diet and
exercise habits throughout the entire study phase which
was monitored by participants keeping a food and activity
diary before and during the study. There were no specific
instructions given to avoid foods containing large
amounts of phenolic compounds, other than abstain
from consuming any alcohol, grapes or grape products as
previously described.
Wine supplementation
The red wine used throughout this study was a Cabernet
Sauvignon, supplied as a cask wine to prevent the oxida-
tion of the wine. This style was chosen since it is known to
be palatable to most people and to the volunteers in the
study. Participants consumed the wine at any time during
the day, however, it was suggested that they do so at a time
when they would normally consume alcohol (e.g. with an
evening meal). Importantly, during the period of supple-
mentation participants were asked to refrain from con-
suming any other sources of alcohol, grapes or grape
products.
Wine composition
The concentrations of total anthocyanins, degree of
anthocyanin ionisation, total phenolic compounds, red
wine colour (density and hue) and two indices providing
a measure of polymerisation of monomeric forms (Chem-
ical age index #1 and #2) were determined by spectropho-
tometric methods [15,16]. Determination of the
concentration of free and bound sulphur dioxide in the
wine was made using the method of Rankine and Pocock
[17]. Alcohol content was provided by the wine producer.
The composition of the wine used in this study was ana-
lysed can be seen in Table 1. All components of the wine
used in this study, except for red wine colour – hue and
free sulfur dioxide, were slightly higher than the red wine
used in a study by Greenrod et al[18].
Analyses of glutathione
Glutathione was measured as it is an important antioxi-
dant in the circulation using a commercially available
colorimetric kit (Northwest Life Sciences) based on the
method of Teitze [19] following the manufactures instruc-
tions. Blood was collected via venipuncture using EDTA
coated tubes and stored at 4°C. Whole blood samples
were then deproteinated mixing aliquots with 100 ul of
cold 5% metaphosphoric acid followed by centrifugation
at 1500 × g for 5 min, the supernatant was then removed
and stored at -20°C awaiting further analysis. All samples
were then assayed for reduced GSH as a batch. This
involved mixing 50 µL of calibrators or samples with 50
µL DTNB reagent and 50 µL glutathione reductase reagent
in the wells of microplate. This reaction mix was then
incubated at ambient temperature for 3 min after which
50 µL NADPH reagent was added to all wells and absorb-
ance values read at 405 nm with data collected at 15 sec
intervals for 3 min. Absorbance values were then plotted
as a function of time for each calibrator and sample. A cal-
ibration curve was then constructed by plotting the ∆
A405/min for each calibrator as a function of the GSH
concentration and the equation for the calibration curve
was then used to calculate the concentration of GSH in all
samples.
Analyses of malondialdehyde
Plasma malondialdehyde was as a marker of lipid peroxi-
dation using a commercially available colorimetric kit
(Northwest Life Sciences) following the manufactures
instructions. Blood was collected via venipuncture using
EDTA coated tubes, stored at 4°C and plasma separated
within 2 hrs by centrifugation at 3000 × g for 10 minutes
at room temperature. Plasma samples were then stored at
-20°C awaiting further analysis. All samples were then
assayed for MDA as a batch. This involved mixing 250 µL
calibrator or sample with 10 µL of Butylated hydroxytolu-
ene reagent, 250 µL Phosphoric acid reagent and 250 µL
2-Thiobarbituric acid reagent. This reaction mix was then
incubated at 60°C for 60 min followed by centrifugation
Table 1: Composition of wine used in study
Compounds Amount
Total Anthocyanins 129 mg/L
Degree of ionisation of 
anthocyanins
24.85 %
Degree of ionisation of 
anthocyanins-abolishing effect of 
sulphur dioxide
31.56 %
Total phenolics 40 a.u.
Total polyphenolsa 1.558 g/L
Red wine colour – density 8.4 a.u.
Red wine colour – hue 0.83 a.u.
Chemical age index #1 0.59 a.u.
Chemical age index #2 0.26 a.u.
Free sulfur dioxide, excluding 
anthocyanin bound sulphur 
dioxide
1.04 mg/L
Alcohol 13.0 %
a Epicatechin equivalents.
a.u. Absorbance units.Page 3 of 8
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samples was then read at 532 nm in a spectrophotometer
(Biorad). Absorbance values for calibrators were then
used to construct a calibration curve and the equation for
calibration curve was then used to calculate the concentra-
tion of MDA in all samples.
Analyses of total antioxidant status
Serum total antioxidant status (TAS) was determined for a
quantitative assessment of in vivo antioxidant status using
a commercially available kit (Randox) based on the trolox
equivalent antioxidant capacity method of Miller [20] fol-
lowing the manufactures instructions. Blood was col-
lected via venipuncture using serum separator tubes,
stored at 4°C and serum separated within 2 hrs. Serum
samples were then stored at -20°C awaiting further analy-
sis. All samples were then assayed for TAS as a batch. This
involved mixing 20 µL calibrator (6-hydroxy-2,5,7,8-
tetramethylchroman-2-carboxylic acid 1.79 mmol/L) or
sample with 1 ml of chromogen (metmyoglobin 6.1
µmol/L, ABTS 610 µmol/L) and incubating at 37°C for 3
min. Initial absorbance was then read at 600 nm in a spec-
trophotometer (Biorad). After which 200 µL of substrate
(hydrogen peroxide 250 µmol/L) was added to calibrator
and sample and incubated at 37°C for 3 min. Final
absorbance was then read at 600 nm. The change in
absorbance value for samples relative to the change in
absorbance of the calibrator was then to calculate the TAS
in all samples. The total antioxidant status of the red wine
(Cabernet Sauvignon) used in this study was also meas-
ured using the same assay.
Analyses of serum glucose and plasma lipids
Serum glucose was determined using a commercial glu-
cose oxidase reagent and standard (Thermo Electron Cor-
poration). This involved mixing 3 µL of calibrator or
sample with 450 µL of glucose oxidase reagent and incu-
bating at 37°C for 5 min. Absorbance of calibrators and
samples was then read at 500 nm in a spectrophotometer
(Biorad). The absorbance value of samples relative to the
absorbance of the calibrator was then to calculate the glu-
cose level in all samples. Plasma triglycerides were deter-
mined using commercially available colorimetric kit
(Thermo Electron Corporation). This involved mixing 6
µL of calibrator or sample with 600 µL of triglyceride rea-
gent and incubating at 37°C for 3 min. Absorbance of cal-
ibrators and samples was then read at 500 nm in a
spectrophotometer (Biorad). The absorbance value of
samples relative to the absorbance of the calibrator was
then to calculate the triglyceride level in all samples. Total
cholesterol was determined using commercially available
colorimetric kit (Thermo Electron Corporation). This
involved mixing 6 µL of calibrator or sample with 600 µL
of cholesterol reagent and incubating at 37°C for 3 min.
Absorbance of calibrators and samples was then read at
500 nm in a spectrophotometer (Biorad). The absorbance
value of samples relative to the absorbance of the calibra-
tor was then to calculate the cholesterol level in all sam-
ples. HDL cholesterol was determined using
commercially available colorimetric kit (Thermo Electron
Corporation). This involved mixing 4 µL of calibrator or
sample with 300 µL of HDL reagent 1 and incubating at
37°C for 5 min. After which 100 µL of HDL reagent 2 was
added to calibrator and sample and incubated at 37°C for
3 min. Absorbance of calibrators and samples was then
read at 600 nm in a spectrophotometer (Biorad). The
absorbance value of samples relative to the absorbance of
the calibrator was then to calculate the triglyceride level in
all samples. LDL cholesterol, a risk factor for cardiovascu-
lar disease, was calculated by subtracting HDL cholesterol
values, a negative risk factor for cardiovascular disease,
from total cholesterol.
Statistical analysis
Statistical analysis was performed using the SPSS statisti-
cal package (version 12.0, SPSS Inc.). All data were distrib-
uted normally and expressed as mean ± standard error of
the mean (SEM). Data from young and older individuals
were analyzed using a three way ANOVA to determine the
effect of wine consumption within the young or old
group, any difference between young and old groups and
any difference between pre samples with the young or old
group. Due to the cross over design of the study any differ-
ence between are not included in the analysis s the pri-
mary focus of the research was to determine the effect of
red wine consumption. In all cases a P value of < 0.05 was
considered statistically significant.
Results
Whole blood glutathione was measured as it is an impor-
tant circulating antioxidant. Before and after red wine
consumption GSH levels were elevated in older volun-
teers compared to young volunteers (P < 0.001, Figure 2).
Despite this difference between young and old volunteers
consumption of red wine had the same effect with both
the young and old groups causing significant reductions
in GSH levels after red wine consumption, young with
wine (P = 0.004) and older with wine periods (P < 0.001,
Figure 2). No significant changes in GSH level were
observed in young and older groups without red wine.
Plasma malondialdehyde was measured as a biomarker of
lipid peroxidation. Before and after red wine consump-
tion MDA levels were reduced in older volunteers com-
pared to young volunteers (P < 0.05, Figure 3). Despite
this difference between young and old volunteers con-
sumption of red wine had the same effect within both the
young and old group causing significant reductions in
MDA levels after red wine consumption, young with wine
(P < 0.001) and older with wine periods (P < 0.001, FigurePage 4 of 8
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young and older groups without red wine.
Serum total antioxidant status was calculated for samples
from each study group. Before red wine consumption TAS
levels were decreased in older volunteers compared to
young volunteers (P < 0.001, Figure 4). Despite this differ-
ence between young and old volunteers consumption of
red wine had the same effect within both the young and
old group demonstrating a significant increase in total
antioxidant status after red wine consumption, young
with wine (P = 0.026) and older with wine periods (P =
0.01, Figure 4). These changes correspond to the changes
in GSH and MDA with red wine consumption for both
young and older groups. The total antioxidant status of
the red wine consumed by all treatment subjects in this
study contained 1.53 ± 0.027 mmol/L of antioxidant
capacity (Figure 4).
There was no significant difference in both age (yrs) and
BMI (kg/m2) between red wine and abstinence periods,
for both young and older population groups (Table 2).
Similarly there were no differences in serum glucose con-
centrations between pre and post samples for both young
and older control and treatment groups (Table 2). Plasma
Plasma malondialdehydeFigure 3
Plasma malondialdehyde. Effect of red wine consumption 
on plasma MDA concentrations from young (18–30 yrs) and 
older (≥ 50 yrs) volunteers. Bars represent mean ± SEM of 
plasma MDA values pre and post two weeks of red wine 
consumption or abstinence. YA, young abstinence; YW, 
young wine; OA, older abstinence; OW older wine. a indi-
cates a significant change with wine P < 0.05. b indicates a sig-
nificant difference between young and old, P < 0.05.
Table 2: Anthropometric and blood lipid measurements
Young (18–30 yrs) Older (≥ 50 yrs)
Abstain Red wine Abstain Red Wine
Age (yrs) 21.7 ± 0.3 21.3 ± 0.4 58.9 ± 2.3 57.2 ± 2.7
BMI (kg/m2) 24.7 ± 1.5 23.6 ± 1.2 32.5 ± 2.2 28.3 ± 2.2
Cholesterol Pre Sample 4.3 ± 0.2 5.1 ± 0.5 5.9 ± 0.3 7.0 ± 0.2
(mmol/L) Post Sample 3.2 ± 0.4 5.1 ± 0.1 5.8 ± 0.3 7.2 ± 0.2
Triglycerides Pre Sample 1.7 ± 0.1 1.96 ± 0.2 2.3 ± 0.2 2.1 ± 0.1
(mmol/L) Post Sample 1.8 ± 0.1 2.3 ± 0.1 2.5 ± 0.1 2.4 ± 0.2
HDL-Cholesterol Pre Sample 31.3 ± 1.6 33.6 ± 2.4 46.3 ± 3.4 42.1 ± 2.4
(mg/dL) Post Sample 37.1 ± 2.6 32.5 ± 2.4 44.3 ± 1.5 41.9 ± 1.9
LDL-Cholesterol Pre Sample 137.5 ± 10.6 115.1 ± 8.2 194.8 ± 10.4 230.1 ± 11.5
(mg/dL) Post Sample 108.0 ± 11.1 131.9 ± 8.8 185.9 ± 10.4 225.5 ± 12.8
Glucose Pre Sample 5.8 ± 0.3 6.1 ± 0.4 6.6 ± 0.5 6.2 ± 0.3
(mmol/L) Post Sample 5.8 ± 0.3 6.1 ± 0.5 6.4 ± 0.46 6.5 ± 0.5
Mean values for age and BMI of young (18–30 yrs) and older (≥ 50 yrs) subjects, together with serum glucose and plasma lipid profiles of pre and 
post samples for each study group. Values are mean ± SEM.
Blood glutathioneFigure 2
Blood glutathione. Effect of red wine consumption on 
blood GSH concentrations from young (18–30 yrs) and older 
(≥ 50 yrs) volunteers. Bars represent mean ± SEM of blood 
GSH values pre and post two weeks of red wine consump-
tion or abstinence. YA, young abstinence; YW, young wine; 
OA, older abstinence; OW older wine. a indicates a signifi-
cant change with wine P < 0.05. b indicates a significant differ-
ence between young and old, P < 0.05.Page 5 of 8
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the determination of plasma cholesterol, plasma triglycer-
ides, plasma HDL-cholesterol and plasma LDL-choles-
terol values. No statistical significance was found for any
of the blood lipid profiles within each study group (Table
2).
Discussion
The results of these experiments show that moderate con-
sumption of red wine significantly altered redox balance
in the circulation of both young and old individuals. Red
wine consumption increased serum antioxidant capacity
and decreased concentrations of plasma malondialde-
hyde and whole blood glutathione in both age groups. In
contrast, concentrations of malondialdehyde, glutath-
ione, and total antioxidant capacity were significantly dif-
ferent between young and old control groups. Old
subjects had greater concentrations of whole blood glu-
tathione and lower concentrations of plasma malondial-
dehyde when compared to young subjects. Furthermore,
total antioxidant capacity in serum was lower in the old
group when compared to the young group. Red wine con-
sumption did not significantly alter plasma lipid profiles
and there were no significant differences between young
and old individuals.
Oxidative stress is the consequence of an imbalance of
oxidants and antioxidants. Studies show that a high con-
sumption of antioxidants can decrease levels of oxidative
stress and decrease the incidence of CVD [14]. In the cur-
rent study TAS increased after red wine consumption these
results strongly suggest that in the presence of red wine
consumption, total antioxidant status has the ability to
increase significantly. This increase was slightly more
prominent in older individuals who increased their TAS
16% after consuming the red wine for two weeks com-
pared to the younger individuals who increased 7%,
despite the fact that young individuals had higher resting
concentrations of total antioxidant status. Our results are
also shared in a study by Fernandez-Pachon and col-
leagues [21], who eluded that antioxidant values deter-
mined before wine intake were statistically different from
those measured 30 minutes after consumption. Our study
however, extends beyond Fernandez-Pachon's by advo-
cating that the consistent consumption of wine may offer
the ability to significantly enhance total antioxidant status
over a longer period. This sustained elevation of TAS fur-
ther confirms that the lower incidence of CVD in popula-
tions who consume red wine on a regular basis [14] is due
to an increase in circulating oxidative protection. In addi-
tion it also suggests that a lifetime of red wine consump-
tion is not needed to achieve a sustained increase in
circulating oxidative protection, two weeks is long enough
to boost TAS.
To further determine the extent of positive effects associ-
ated with and increase in TAS we measured MDA, as a
biomarker of lipid peroxidation and found that there were
significant reductions in MDA after red wine consump-
tion for both young and older volunteers. This suggests
that the consumption of red wine was also effective in
protecting circulating lipid systems from oxidative dam-
age in young and older volunteers. Whereas, young and
older groups experienced no changes in MDA values with-
out red wine. These results indicate that MDA as a marker
of circulating lipid oxidation was significantly reduced,
thereby representing a significant reduction in lipid perox-
idation in participants who consumed the red wine. Our
results are complimented by studies published by Fuhr-
man [22], which show that the propensity of lipids to
undergo peroxidation was reduced by 20% in correspond-
ence with the consumption of 400 mL/day of red wine for
2 weeks. Moreover, our results suggest that the antioxi-
dant effect of dietary red wine on plasma lipid peroxida-
tion could be related to the elevation of polyphenol
concentration in plasma. Interestingly, the young group
had higher levels of MDA compared with the older group
prior to red wine consumption. This was an unexpected
result, as theoretically it is believed that oxidative damage
such as lipid peroxidation increases with age [23].
In addition to measuring TAS and MDA in the current
study the levels of whole blood GSH were measured and
it was found that red wine consumption decreased GSH in
young and older volunteers. However, there were no sig-
nificant reductions in GSH levels in the absence of red
Serum total antioxidant statusFig re 4
Serum total antioxidant status. Effect of red wine con-
sumption on serum TAS from young (18–30 yrs) and older 
(≥ 50 yrs) volunteers. Bars represent mean ± SEM of serum 
TAS pre and post two weeks of red wine consumption or 
abstinence. YA, young abstinence; YW, young wine; OA, 
older abstinence; OW older wine; RW red wine a indicates a 
significant change with wine P < 0.05. b indicates a significant 
difference between young and old, P < 0.05.Page 6 of 8
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be due to it being down regulated as a result of the
increased level antioxidants derived from red wine elimi-
nating additional reactive oxygen species. In addition, it
would appear that the level of protection conferred was
greatest amongst younger participants which demon-
strated a 55% reduction in GSH levels compared to older
participants who had a 44% reduction in GSH, after both
groups consumed red wine. It was expected and conse-
quently demonstrated in this study, that the older popu-
lation groups have a higher resting GSH content
compared with their younger counterparts. This data may
be interpreted with respect to the free-radical theory of
ageing, in which endogenous oxidative damage occurs at
higher frequencies with older age [24]. Data from Fenech
et al [25] showed that the protective effects against DNA
damage could not be readily explained by the phenolic
content of the red wine, however, in a subsequent study
by Greenrod et al [18] their data suggested that the non-
alcoholic fraction of red wine protects DNA from oxida-
tive damage, however, this effect is not solemnly
explained by the antioxidant catechin.
No significant difference in age and BMI between young
or old volunteers was observed before or after red wine
consumption. This data indicates that potential changes
in BMI had no influence on interpretation of the data. As
the results of this present study indicate, no significant
changes in plasma cholesterol, triglycerides, HDL-choles-
terol, LDL-cholesterol and serum glucose were evidenced
before and after red wine consumption (Table 2). Our
data provides evidence that corresponds to research by
Akcay and colleagues [26] whose findings suggest there is
no significant difference in LDL blood levels with respect
to the consumption of a cabernet sauvignon red wine.
From our data, relationships may be draw with respect to
the consumption of red wine. We found that both young
and older volunteers demonstrated significant decreases
in GSH and MDA and this was proportional to the serum
increases in total antioxidant status. This data signifies the
relationship between a reduction in antioxidant levels and
lipid oxidation and an increase in antioxidant status, with
the consumption of 400 ml/day of red wine for 2 weeks.
This finding is important with respect to the long-term
implications of red wine consumption. It suggests that the
consistent consumption of red wine may confer pro-
longed oxidative protection, as opposed to conflicting
research, which suggests plasma polyphenols only peak at
3 hours post consumption [21]. Our study controlled for
these factors, where participants abstained from consum-
ing any alternative alcoholic sources, grapes or grape
products during the course of the study, as well as all
blood samples were taken after 12–14 hrs fasting. Our
findings shed further light on the nature of the beneficial
effects of red wine consumption and gives supporting evi-
dence for the recommendation that red wine provides
protective effects for CVD. Also, drinking pattern and not
just the total amount of red wine consumed is important
in the association between intake and protection.
Conclusion
In conclusion red wine consumption decreases oxidative
stress and enhances total antioxidant capacity in the circu-
lation. This decrease in oxidative stress and increase in
total antioxidant capacity in circulation is important as
the opposite set of circumstances has been implicated in
the pathogenesis of CVD. The results produced from this
study suggest that the potent antioxidant properties pro-
vided by red wine and potential protection from develop-
ing CVD highlight the relationship between red wine
consumption and health.
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